KASHMAN; YOEL

Patent Applications and Registrations

Patent applications and USPTO patent grants for KASHMAN; YOEL.The latest application filed is for "anti-neuroinflammatory and protective compounds in achillea fragrantissima".

Company Profile

0.14.9

KASHMAN; YOEL - TEL AVIV IL
Kashman; Yoel - Tel Aviv-Yafo IL
Kashman; Yoel - Ramat Aviv IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-neuroinflammatory And Protective Compounds In Achillea Fragrantissima App 20170020842 - ELMANN; Anat ; et al.	2017-01-26
Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof Grant 9,284,274 - Kashman , et al. March 15, 2	2016-03-15
Method of regenerating connective tissue with a scaffold of coral-derived collagen Grant 8,747,484 - Benayahu , et al. June 10, 2	2014-06-10
Coral-derived Collagen And Methods Of Farming Same App 20130302895 - BENAYAHU; Yehuda ; et al.	2013-11-14
Coral-derived collagen and methods of farming same Grant 8,552,153 - Benayahu , et al. October 8, 2	2013-10-08
Coral-derived Collagen And Methods Of Farming Same App 20110038914 - Benayahu; Yehuda ; et al.	2011-02-17
Salarins And Tulearins, Compositions And Uses Thereof App 20100311757 - Kashman; Yoel ; et al.	2010-12-09
Jasmonate derivative compounds pharmaceutical compounds and methods of use thereof Grant 7,683,211 - Flescher , et al. March 23, 2	2010-03-23
Chemical Derivatives Of Jasmonate, Pharmaceutical Compositions And Methods Of Use Thereof App 20090291904 - Kashman; Yoel ; et al.	2009-11-26
Jasmonate Derivative Compounds, Pharmaceuticals Compounds and Methods of Use Thereof App 20080319066 - FLESCHER; Eliezer ; et al.	2008-12-25
Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof Grant 7,425,651 - Flescher , et al. September 16, 2	2008-09-16
Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof App 20070142474 - Flescher; Eliezer ; et al.	2007-06-21
Anti-microbial-adhesion fraction derived from vaccinium Grant 6,843,993 - Ofek , et al. January 18, 2	2005-01-18
Calanolide and related antiviral compounds, compositions, and uses thereof Grant 6,774,141 - Boyd , et al. August 10, 2	2004-08-10
Calanolide and related antiviral compounds, compositions, and uses thereof Grant 6,673,830 - Boyd , et al. January 6, 2	2004-01-06
Cytotoxic alkaloids halitulin Grant 6,635,656 - Kashman , et al. October 21, 2	2003-10-21
Calanolide and related antiviral compounds, compositions, and uses thereof App 20020086898 - Boyd, Michael R. ; et al.	2002-07-04
Anti-microbial-adhesion fraction derived from vaccinium App 20020048611 - Ofek, Itzhak ; et al.	2002-04-25
Cytotoxic pyridoacridine alkaloids Grant 6,350,743 - Kashman , et al. February 26, 2	2002-02-26
Anti-microbial-adhesion fraction derived from vaccinium Grant 6,303,125 - Ofek , et al. October 16, 2	2001-10-16
Hemiasterlin and geodiamolide TA Grant 5,661,175 - Kashman , et al. August 26, 1	1997-08-26
Topsentin compounds effective against viruses and certain tumors Grant 4,866,084 - Gunasekera , et al. September 12, 1	1989-09-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.